Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours2018 · 76 citations
2. 2Concordance of ATM (Ataxia Telangiectasia Mutated) Immunohistochemistry between Biopsy or Metastatic Tumor Samples and Primary Tumors in Gastric Cancer Patients2013 · 58 citations
3. 3The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer2019 · 1,317 citations
4. 4Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer2019 · 2,285 citations
5. 5Pathogenic Germline Variants in 10,389 Adult Cancers2018 · 900 citations